| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K04800985 |
| PharmacoGx | BRD-K04800985 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NACA | CTRPv2 | pan-cancer | AAC | -0.094 | 0.03 |
| mRNA | CBWD3 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | NDUFAF7 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | OSBPL7 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.03 |
| mRNA | KLF17 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.03 |
| mRNA | ADAM17 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.03 |
| mRNA | TAS2R39 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | ADORA1 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.03 |
| mRNA | ZNF575 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | CLCC1 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.03 |
